Mesenchymal stem cell exosome eye atomization administration device
The mesenchymal stem cell exosome eye atomization drug delivery device addresses the challenges of ocular drug administration by using a strap-worn, motor-driven mechanism to deliver drugs directly to the eyes with precision and efficiency, reducing contamination and infection risk.
Patent Information
- Application Number
- CN202411400605.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-09
- Publication Date
- 2024-12-06
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Current ocular drug administration methods, including eye drops and atomization, are cumbersome, difficult to align, prone to contamination, and risk eye infections due to environmental pollutants, and lack precision and efficiency.
A mesenchymal stem cell exosome eye atomization drug delivery device with a strap-worn design, utilizing a motor-driven atomization mechanism with gears, grooved wheel shaft, and swing connecting rods to deliver drugs directly to the eyes, ensuring constant distance and position, reducing contamination risk, and enhancing delivery accuracy and efficiency.
The device provides a simple, efficient, and precise drug delivery method that minimizes contamination and infection risk while ensuring consistent drug delivery to the eyes, adapting to different needs and improving applicability and application range.
Smart Images

Figure CN119074376A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of medical auxiliary equipment, and in particular to an eye atomization drug delivery device for mesenchymal stem cell exosomes. Background Art
[0002] Mesenchymal stem cells are a type of precursor cell that is widely present in a variety of tissues and organs and has the potential for self-renewal and multiple differentiation. Cutting-edge regenerative medicine technology can use mesenchymal stem cells to regenerate damaged tissues and organs, or to replicate the required tissues and organs in vitro for replacement therapy.
[0003] Ocular therapeutic drugs can exert local therapeutic effects and systemic therapeutic effects through the corneal route and conjunctival route respectively. However, due to the complex physiological structure of the eye and the existence of many barriers, ocular drug administration is a challenge. At present, ocular medications are mostly applied to the eyes by dripping. Specifically, in order to ensure that eye drops can enter the eyes, when applying eye drops, the head is tilted back or lying flat, and then the upper and lower eyelids are pushed up and down with fingers to increase the exposed area of the eyeball, so that the mouth of the eye drop bottle can be aligned with the eyeball, and the eye drops in the bottle are dripped into the user's eyes by squeezing the eye drop bottle. However, this way of dripping eye drops is not only troublesome, but also the mouth of the eye drop bottle is not easy to align with the eyeball, and the eye drops are difficult to enter the eye. In order to allow the eye drops to be directly facing the eyeball, the mouth of the eye drop bottle is usually close to the user's eyes, and even touches the user's eyes. This contact drug administration is not only easy to cause the eye drops to be contaminated, but also easy to cause the user's eyes to be infected.
[0004] Eye atomization is an innovative ophthalmic treatment method. Its core lies in delivering drugs directly to the eyes through atomization. The atomized drug particles are tiny and can penetrate the tear layer and corneal epithelium on the surface of the eye, directly acting on the lesion site, which can effectively improve the penetration and absorption of drugs in the eye, reduce drug waste and side effects, and improve the treatment effect. The existing eye atomization method is similar to drip administration. The eye drops are atomized before administration, and then the atomized eye drops are sprayed into the eyes. The eyes are opened with fingers to increase the exposed area of the eyeball. Not only is the operation troublesome, but the nozzle of the atomizer is not easy to aim at the eyeball; in addition, the distance between the nozzle and the eye is large, and pollutants such as dust, smoke, and bacteria in the environment can easily enter the eye with the atomized gas, causing infection or aggravating eye diseases; constantly reducing the distance between the nozzle and the eye is easy to contaminate the atomizer nozzle. Summary of the invention
[0005] The present invention is intended to provide a mesenchymal stem cell exosome eye atomization drug delivery device, which uses a strap to wear the entire atomization drug delivery device on the head, and uses the atomization drug delivery component to deliver drugs to the eyes, without the need to use fingers to open the eyelids, and the drug delivery operation is simple; and the drug delivery position and distance are fixed, the drug delivery effect is good, the efficiency is high, and the probability of eye drops being contaminated or the eyes being infected is low. The problems in the background technology are solved.
[0006] In order to achieve the above object, the present invention provides the following technical solutions:
[0007] A mesenchymal stem cell exosome ocular atomization drug delivery device, comprising a base shell and an atomization drug delivery component, wherein the base shell is connected to a motor and a strap; the atomization drug delivery component comprises a driven gear, a grooved wheel shaft, a swing connecting rod, a fixed groove body, an eye disc, a drug delivery barrel and an eye drop bottle, wherein the driven gear and the grooved wheel shaft are both rotatably connected to the base shell, and the driven gear and the grooved wheel shaft are coaxially fixedly connected, and the output shaft of the motor is fixedly connected to a driving gear that meshes with the driven gear; the fixed groove body and the drug delivery barrel are both fixedly connected to the base shell, and the eye disc rotates with the base shell The eye disc is connected with an atomizing nozzle; the groove wheel shaft is provided with an oblique groove, and the middle part of the swing connecting rod is sleeved on the outer side of the groove wheel shaft through the oblique groove, one end of the swing connecting rod is rotatably connected with the eye disc, and the end of the swing connecting rod away from the eye disc is fixedly connected with a linkage shaft, and the linkage shaft is slidably penetrated through the fixed groove body; the medication barrel is slidingly sealed and connected with a push-pull rod, and the push-pull rod is rotatably connected with the linkage shaft through the linkage rod; the liquid inlet end and the liquid outlet end of the medication barrel are respectively connected with the eye drops bottle and the atomizing nozzle through a liquid guide tube.
[0008] Furthermore, the atomization drug delivery assembly further comprises a fixed plate and a sliding block, wherein the fixed plate is fixedly connected to the base shell, the sliding block is fixedly connected to the push-pull rod, and the sliding block is slidably connected to the fixed plate.
[0009] Furthermore, the fixing plate is provided with a convex-shaped sliding groove, the sliding block is also convex-shaped, and the sliding block is slidably arranged on the inner side of the sliding groove.
[0010] Furthermore, a silicone sleeve is sleeved on the outer side of the eye disc, a plurality of protrusions are arranged on the end surface of the silicone sleeve, and the atomizing nozzle is arranged on the inner side of the plurality of protrusions.
[0011] Furthermore, the atomizing nozzle is elliptical in shape, and the distance between the medicine outlet end surface of the atomizing nozzle and the end surface of the protrusion is not greater than 5 cm.
[0012] Furthermore, the angle between the central axis of the inclined groove and the central axis of the sheave shaft is 30-45°.
[0013] Furthermore, the liquid guide tube connected to the liquid inlet end and the liquid guide tube connected to the liquid outlet end of the dosing cartridge are both connected to a one-way valve. The one-way valve connected to the liquid inlet end is used to control the eye drops to flow only from the eye drop bottle to one side of the dosing cartridge, and the one-way valve connected to the liquid outlet end is used to control the eye drops to flow only from the dosing cartridge to one side of the atomizing nozzle.
[0014] Furthermore, there are two atomization drug administration components, and the two atomization drug administration components are mirror-symmetrically arranged with the vertical center plane of the base shell as the reference plane; the motor is a dual-output shaft motor, and the two output shafts of the motor are both connected to the driving gear, and the two driving gears are respectively meshed with the driven gears of the two atomization drug administration components.
[0015] Furthermore, the eye drops bottle is detachably clamped on the inner side of the base shell; the base shell is detachably connected to an outer shell for installing and / or removing the eye drops bottle.
[0016] Furthermore, the base shell is in an annular arc shape, the binding belt is an elastic belt, and the two ends of the binding belt are connected to the two ends of the base shell, and the atomization drug delivery assembly is arranged between the base shell and the binding belt.
[0017] The principle and beneficial effects of the technical solution are:
[0018] 1. The present invention provides a mesenchymal stem cell exosome eye atomization drug delivery device, wherein a strap is connected to the base shell so that the entire eye atomization drug delivery device can be fixedly worn on the head, and the drug delivery distance (the distance between the drug outlet of the eye drops and the drug delivery eyeball) is constant during drug delivery, thereby reducing the probability of the atomized eye drops contacting with pollutants such as dust, smoke, and bacteria in the surrounding environment, thereby reducing the probability of the eye drops being contaminated or the eyes being infected, and the relative position of drug delivery (the position between the drug outlet position of the eye drops and the drug delivery eyeball) is constant, thereby improving the accuracy and effect of drug delivery; the atomization drug delivery component comprises a driven gear, a groove wheel shaft, a swing connecting rod, a fixed groove body, an eye plate, a drug delivery barrel and an eye drop bottle, the driven gear is meshed with the driving gear, and the driven gear is also coaxially fixedly connected to the groove wheel shaft, and the motor starts to run and drives the driven gear and the groove wheel shaft to rotate under the action of the driving gear; an inclined groove is provided on the groove wheel shaft, and a swing connecting rod ... The swing connecting rod is sleeved through the inclined groove, and one end of the swing connecting rod is rotatably connected to the eye disc, and the eye disc is rotatably connected to the base shell. The linkage shaft fixedly connected to the other end of the swing connecting rod is slidably connected to the fixed groove body. When the groove wheel shaft rotates, the swing connecting rod swings under the action of the fixed groove body and the eye disc, and the swing of the swing connecting rod drives the linkage shaft to slide along the axial direction of the fixed groove body, thereby driving the eye disc to rotate relative to the base shell; the linkage shaft is rotatably connected to the push-pull rod through the linkage rod, and the push-pull rod is slidably and sealably connected to the drug delivery cylinder, the liquid inlet end and the liquid outlet end of the drug delivery cylinder are respectively connected to the eye drop bottle and the atomizing nozzle, when the linkage shaft pulls the push-pull rod to move away from the drug delivery cylinder, the drug delivery cylinder draws liquid from the eye drop bottle and stores it inside, and when the linkage shaft pushes the push-pull rod to make it close to the drug delivery cylinder, the drug delivery cylinder pushes out the eye drops inside it and acts on the eyeball through the atomizing nozzle; that is, the drug delivery to the eye can be completed by starting the motor, and the drug delivery operation is simple and efficient;
[0019] 2. The present invention provides a mesenchymal stem cell exosome eye atomization drug delivery device, wherein the atomization drug delivery component also includes a fixed plate and a slider, and the fixed plate fixedly connected to the base shell is provided with a "convex"-shaped slide groove, and the slider fixedly connected to the push-pull rod is also "convex"-shaped, and the slider is slidably arranged on the inner side of the slide groove, so that when the linkage shaft drives the push-pull rod to move axially of the drug delivery barrel under the action of the linkage rod, the slider moves in the slide groove, guides and limits the movement of the push-pull rod, ensures the linearity requirement during the movement, ensures the stability and uniformity during the movement, and thus ensures the atomization drug delivery functionality of the entire atomization drug delivery device;
[0020] 3. The present invention provides a mesenchymal stem cell exosome eye atomization drug delivery device, in which a silicone sleeve is sleeved on the outer side of the eye disc, and the silicone sleeve is sleeved on the outer side of the eye disc and contacts the patient's eye. When it is reused or used by different patients, the silicone sleeve can be removed to disinfect and sterilize it to ensure the sterility requirements of the equipment; a plurality of protrusions are provided on the silicone sleeve, so that there is a distance between the atomizer nozzle and the eye to avoid direct contact between the two and cause contamination of the eye and / or the atomizer nozzle; the atomizer nozzle is set to an elliptical shape, and the elliptical shape is The atomizing nozzle with a shape of 1 / 2" increases the area of drug delivery to the eyeball, improving the drug delivery effect and uniformity; the atomizing nozzle is arranged on the inner side of several protrusions of the silicone sleeve, and when the silicone sleeve swings relative to the base shell with the eye disc, the protrusions at different positions on the silicone sleeve open the upper eyelid and / or lower eyelid of the eye, so as to facilitate drug delivery by the atomizing nozzle and improve the drug delivery effect; the distance between the drug delivery end face of the atomizing nozzle and the end face of the protrusion is controlled to reduce the contact time and area of the atomized medicine with the external environment, thereby reducing the probability of eye drops being contaminated or the eyes being infected;
[0021] 4. In the mesenchymal stem cell exosome ocular atomization drug delivery device provided by the present invention, the angle between the central axis of the inclined groove and the central axis of the groove wheel shaft is controlled at 30-45°, and the groove wheel shaft drives the swing connecting rod to move. By controlling the angle between the central axis of the inclined groove and the central axis of the groove wheel shaft, the axial movement distance of the linkage shaft can be controlled, and the movement distance of the push-pull rod along the axial direction of the drug delivery cylinder can be controlled, so as to complete the control of the atomization drug delivery amount of each extraction and push-out, that is, different angles correspond to different single drug delivery amounts, which can adapt to the drug delivery needs of different actual situations, and improve the applicability and application range of the entire atomization drug delivery device;
[0022] 5. The present invention provides a mesenchymal stem cell exosome eye atomization drug delivery device, in which the liquid guide tube connected to the liquid inlet end and the liquid guide tube connected to the liquid outlet end of the drug delivery cylinder are both connected to a one-way valve to control the flow of the drug solution, thereby improving the accuracy of drug delivery; two atomization drug delivery components are provided, and the two atomization drug delivery components are mirror-symmetrically arranged with the vertical center plane of the base shell as the reference plane, so that they act on the drug delivery of two eyes at the same time, thereby improving the efficiency of drug delivery;
[0023] 6. The present invention provides a mesenchymal stem cell exosome eye atomization drug delivery device, in which an eye drop bottle is clamped on the inner side of a base shell, and the base shell is detachably connected to the outer shell to facilitate the replacement of eye drops, thereby improving the convenience of operation; the base shell is arranged in an annular arc shape, the strap is an elastic strap, and the two ends of the strap are connected to the two ends of the base shell, and the atomization drug delivery component is arranged between the base shell and the strap, and the elastic strap can adapt to different head sizes and wearing methods, so that the entire atomization device can be firmly worn on the head, thereby ensuring the stability, efficiency and accuracy of drug delivery during the drug delivery process. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 This is a front view of a mesenchymal stem cell exosome eye atomization drug delivery device of the present invention;
[0025] Figure 2 for Figure 1 Sectional view of AA in the middle;
[0026] Figure 3 This is a top view of a mesenchymal stem cell exosome eye atomization drug delivery device of the present invention;
[0027] Figure 4 This is a schematic diagram of the structure of a mesenchymal stem cell exosome eye atomization drug delivery device of the present invention;
[0028] Figure 5 A top view of an atomization drug delivery component of a mesenchymal stem cell exosome eye atomization drug delivery device of the present invention;
[0029] Figure 6 This is a schematic structural diagram of an atomization drug delivery component of a mesenchymal stem cell exosome eye atomization drug delivery device of the present invention.
[0030] The names of the corresponding marks in the accompanying drawings are:
[0031] Base shell 1, motor 2, driving gear 3, driven gear 4, grooved wheel shaft 5, swing connecting rod 6, fixed groove body 7, eye plate 8, linkage shaft 9, medication barrel 10, push-pull rod 11, linkage rod 12, eye drop bottle 13, silicone sleeve 14, protrusion 15, atomizing nozzle 16, fixing plate 17, slider 18, shell 19, binding band 20, one-way valve 21. DETAILED DESCRIPTION
[0032] The present invention is further described in detail below in conjunction with the accompanying drawings and embodiments:
[0033] like Figures 1 to 6 As shown, a mesenchymal stem cell exosome ocular atomization drug delivery device comprises a circular arc-shaped base shell 1 and two groups of atomization drug delivery components, both ends of the base shell 1 are connected with elastic straps 20, the two atomization drug delivery components are arranged between the base shell 1 and the straps 20, and the two atomization drug delivery components are arranged in a mirror-symmetrical manner with the vertical center plane of the base shell 1 as a reference plane;
[0034] The atomizing drug delivery component comprises a driven gear 4, a grooved wheel shaft 5, a swing connecting rod 6, a fixed groove body 7, an eye plate 8, a drug delivery tube 10, an eye drop bottle 13, a fixed plate 17 and a slider 18. The driven gear 4 and the grooved wheel shaft 5 are both rotatably connected to the base shell 1, and the driven gear 4 and the grooved wheel shaft 5 are coaxially fixedly connected. A motor 2 is fixedly connected to the inner side of the base shell 1, and the motor 2 is a double-output shaft motor 2. The two output shafts of the motor 2 are both connected to a driving gear 3. The two driving gears 3 are respectively meshed with the driven gears 4 of the two atomizing drug delivery components; the eye plate 8 is rotatably connected to the base shell 1, and a silicone sleeve 14 is sleeved on the outer side of the eye plate 8. The end surface of the silicone sleeve 14 is provided with eight protrusions 15. The eye plate 8 is also connected to an elliptical atomizing nozzle 16, and the atomizing nozzle 16 is arranged on the inner side of the eight protrusions 15, and the drug outlet end surface of the atomizing nozzle 16 is connected to the base shell 1. The distance between the end faces of the protrusion 15 is 5 cm; the fixed groove body 7, the drug delivery barrel 10 and the fixed plate 17 are all fixedly connected to the base shell 1, the groove wheel shaft 5 is provided with an oblique groove, and the angle between the central axis of the oblique groove and the central axis of the groove wheel shaft 5 is 45°. The middle part of the swing link 6 is sleeved on the outer side of the groove wheel shaft 5 through the oblique groove, and one end of the swing link 6 is rotatably connected to the eye plate 8. The end of the swing link 6 away from the eye plate 8 is fixedly connected with a linkage shaft 9, and the linkage shaft 9 is slidably penetrated in the fixed groove body 7; the drug delivery barrel 10 is slidably and sealedly connected with a push-pull rod 11, and the push-pull rod 11 is rotatably connected to the linkage shaft 9 through a linkage rod 12, and the slider 18 is fixedly connected to the lower side of the push-pull rod 11. The upper surface of the fixed plate 17 is provided with a "convex"-shaped slide groove, and the slider 18 is also "convex"-shaped, and the slider 18 is slidably arranged on the inner side of the slide groove;
[0035] The liquid inlet end and the liquid outlet end of the dosing cartridge 10 are connected to the eye drop bottle 13 and the atomizing nozzle 16 respectively through a liquid conduit, and the conduits are both connected to a one-way valve 21. The one-way valve 21 connected to the liquid inlet end is used to control the eye drops to flow only from the eye drop bottle 13 to one side of the dosing cartridge 10, and the one-way valve 21 connected to the liquid outlet end is used to control the eye drops to flow only from the dosing cartridge 10 to the atomizing nozzle 16; the eye drop bottle 13 is clamped on the inner side of the base shell 1, and the base shell 1 is clamped with an outer shell 19, and the outer shell 19 is removed to install and / or disassemble the eye drop bottle 13.
[0036] The specific implementation process is as follows:
[0037] When using the present atomizing drug delivery device, open the outer shell 19 from the base shell 1, connect the new eye drop bottle 13 to the drug delivery barrel 10 through the catheter, and snap it into place on the inner side of the base shell 1, and then install the outer shell 19; then use the strap 20 to wear the entire device on the head so that the protrusion 15 on the silicone sleeve 14 abuts against the upper eyelid and / or lower eyelid of the eye, adjust the position of the base shell 1 so that the eyeballs of the two eyes are aligned with the atomizing nozzles 16 of the two atomizing drug delivery components respectively; finally, start the motor 2 to perform atomizing drug delivery to the eyes; after the drug delivery is completed, the silicone sleeve 14 can be optionally removed from the eye tray 8 for disinfection / sterilization to facilitate secondary use or use by others.
[0038] The eye drops bottle 13 is clamped on the inner side of the base shell 1, and the eye drops can be replaced by removing the outer shell 19, which is highly convenient to operate; the base shell 1 is an annular arc shape, the strap 20 is an elastic strap, and the two ends of the strap 20 are connected to the two ends of the base shell 1, and the atomization drug delivery component is arranged between the base shell 1 and the strap 20. The elastic strap 20 can adapt to different head sizes and wearing methods, and the entire atomization device can be worn firmly on the head, and the stability, efficiency and accuracy of drug delivery during the drug delivery process are good;
[0039] The motor 2 drives the driven gear 4 and the grooved wheel shaft 5 to rotate under the action of the driving gear 3. When the grooved wheel shaft 5 rotates, the swing link 6 swings under the action of the fixed slot body 7 and the eye plate 8. The swing of the swing link 6 drives the linkage shaft 9 to slide along the axial direction of the fixed slot body 7, thereby driving the eye plate 8 to rotate relative to the base shell 1; when the linkage shaft 9 pulls the push-pull rod 11 to make it away from the dosing cylinder 10, the dosing cylinder 10 draws the liquid from the eye drop bottle 13 and stores it inside it. When the linkage shaft 9 pushes the push-pull rod 11 to make it close to the dosing cylinder 10, the dosing cylinder 10 pushes out the eye drops inside it, and acts on the eyeball through the atomizing nozzle 16, so that the dosing operation is simple and efficient; wherein, by controlling the angle between the central axis of the inclined slot and the central axis of the grooved wheel shaft 5, the axial movement distance of the linkage shaft 9 can be controlled, and the axial movement distance of the push-pull rod 11 along the dosing cylinder 10 can be controlled, so as to complete the control of the atomized dosing amount drawn and pushed out each time, and can adapt to the dosing needs of different actual situations, and improve the applicability and application range of the entire atomizing dosing device;
[0040] The fixing plate 17 fixedly connected to the base shell 1 is provided with a "convex" shaped slide groove, and the slider 18 fixedly connected to the push-pull rod 11 is also "convex" shaped. When the linkage shaft 9 drives the push-pull rod 11 to move axially in the drug delivery barrel 10 under the action of the linkage rod 12, the slider 18 moves in the slide groove to guide and limit the movement of the push-pull rod 11, ensuring the linearity requirement during the movement, ensuring the stability and uniformity during the movement, thereby ensuring the atomization drug delivery functionality of the entire atomization drug delivery device;
[0041] The silicone sleeve 14 is sleeved on the outside of the eye plate 8 and contacts the patient's eyes. When it is reused or used by different patients, the silicone sleeve 14 can be removed for disinfection and sterilization to ensure the sterility requirements of the equipment; a protrusion 15 is provided on the silicone sleeve 14 so that there is a distance between the atomizing nozzle 16 and the eye to avoid direct contact between the two and contamination of the eye and / or the atomizing nozzle 16; the atomizing nozzle 16 is elliptical, which increases the area of drug administration to the eyeball and improves the effect and uniformity of drug administration; the atomizing nozzle 16 is arranged on the inner side of a plurality of protrusions 15, and when the silicone sleeve 14 swings relative to the base shell 1 with the eye plate 8, the protrusions 15 at different positions on the silicone sleeve 14 open the upper eyelid and / or lower eyelid of the eye to facilitate drug administration by the atomizing nozzle 16, thereby improving the effect of drug administration; the distance between the drug discharging end face of the atomizing nozzle 16 and the end face of the protrusion 15 is controlled to reduce the contact time and area of the atomized medicine with the external environment, thereby reducing the probability of eye drops being contaminated or the eyes being infected;
[0042] The liquid guide tube connected to the liquid inlet end and the liquid guide tube connected to the liquid outlet end of the drug delivery barrel 10 are both connected to a one-way valve 21 to control the flow of the drug solution, thereby improving the accuracy of drug delivery; two atomization drug delivery components are provided, and the two atomization drug delivery components are mirror-symmetrically arranged with the vertical center plane of the base shell 1 as the reference plane, so that they can act on the drug delivery of two eyes at the same time, thereby improving the efficiency of drug delivery.
[0043] The above is only an embodiment of the present invention, and the common knowledge such as the known specific technical solutions or characteristics in the solution is not described in detail here. It should be pointed out that for those skilled in the art, several modifications and improvements can be made without departing from the technical solution of the present invention, which should also be regarded as the protection scope of the present invention, and these will not affect the effect of the implementation of the present invention and the practicality of the patent. The scope of protection required by this application shall be based on the content of its claims, and the specific implementation methods and other records in the specification can be used to interpret the content of the claims.
Claims
1. A mesenchymal stem cell exosome ocular atomization drug delivery device, comprising a base shell and an atomization drug delivery component, wherein the base shell is connected to a motor and a strap; characterized in that: The atomizing drug delivery assembly comprises a driven gear, a grooved wheel shaft, a swinging connecting rod, a fixed groove body, an eye disc, a drug delivery barrel and an eye drop bottle, wherein the driven gear and the grooved wheel shaft are both rotatably connected to the base shell, and the driven gear and the grooved wheel shaft are coaxially fixedly connected, and the output shaft of the motor is fixedly connected to a driving gear that meshes with the driven gear; the fixed groove body and the drug delivery barrel are both fixedly connected to the base shell, the eye disc is rotatably connected to the base shell, and the eye disc is connected to an atomizing nozzle; the grooved wheel shaft is provided with a There is an inclined groove, and the middle part of the swing connecting rod is sleeved on the outer side of the groove wheel shaft through the inclined groove, one end of the swing connecting rod is rotatably connected to the eye disc, and the end of the swing connecting rod away from the eye disc is fixedly connected with a linkage shaft, and the linkage shaft is slidably penetrated through the fixed groove body; the medication barrel is slidingly sealed and connected with a push-pull rod, and the push-pull rod is rotatably connected to the linkage shaft through the linkage rod; the liquid inlet end and the liquid outlet end of the medication barrel are respectively connected with the eye drops bottle and the atomizing nozzle through a liquid guide tube.
2. The mesenchymal stem cell exosome ocular atomization drug delivery device according to claim 1, characterized in that: The atomizing drug delivery assembly further comprises a fixing plate and a sliding block, wherein the fixing plate is fixedly connected to the base shell, the sliding block is fixedly connected to the push-pull rod, and the sliding block is slidably connected to the fixing plate.
3. The mesenchymal stem cell exosome ocular atomization drug delivery device according to claim 2, characterized in that: The fixed plate is provided with a "convex" shaped sliding groove, the sliding block is also "convex" shaped, and the sliding block is slidably arranged on the inner side of the sliding groove.
4. The mesenchymal stem cell exosome ocular atomization drug delivery device according to claim 1, characterized in that: The outer side of the eye plate is sleeved with a silicone sleeve, the end surface of the silicone sleeve is provided with a plurality of protrusions, and the atomizing nozzle is arranged on the inner side of the plurality of protrusions.
5. The mesenchymal stem cell exosome ocular atomization drug delivery device according to claim 4, characterized in that: The atomizing nozzle is elliptical in shape, and the distance between the medicine outlet end surface of the atomizing nozzle and the end surface of the protrusion is no more than 5 cm.
6. The mesenchymal stem cell exosome ocular atomization drug delivery device according to claim 1, characterized in that: The angle between the central axis of the inclined groove and the central axis of the sheave shaft is 30-45°.
7. The mesenchymal stem cell exosome ocular atomization drug delivery device according to claim 1, characterized in that: The liquid guide tube connected to the liquid inlet end and the liquid guide tube connected to the liquid outlet end of the dosing barrel are both connected to a one-way valve. The one-way valve connected to the liquid inlet end is used to control the eye drops to flow only from the eye drop bottle to one side of the dosing barrel, and the one-way valve connected to the liquid outlet end is used to control the eye drops to flow only from the dosing barrel to one side of the atomizing nozzle.
8. The mesenchymal stem cell exosome ocular atomization drug delivery device according to claim 1, characterized in that: There are two atomization drug administration components, and the two atomization drug administration components are arranged in mirror symmetry with the vertical center plane of the base shell as the reference plane; the motor is a dual-output shaft motor, and the two output shafts of the motor are connected to the driving gear, and the two driving gears are respectively meshed with the driven gears of the two atomization drug administration components.
9. The mesenchymal stem cell exosome ocular atomization drug delivery device according to claim 1, characterized in that: The eye drop bottle is detachably clamped on the inner side of the base shell; the base shell is detachably connected to an outer shell for installing and / or removing the eye drop bottle.
10. The mesenchymal stem cell exosome ocular atomization drug delivery device according to claim 1, characterized in that: The base shell is in an annular arc shape, the binding belt is an elastic belt, and the two ends of the binding belt are connected to the two ends of the base shell, and the atomizing drug delivery component is arranged between the base shell and the binding belt.
Citation Information
Cited By
Mesenchymal stem cell exosome eye atomization administration device
CN120771013A
